S

Septerna

Licenses GPCR discovery platform to pharma

Director/Senior Director - AI/ML for Drug Discovery

Applied Machine LearningConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USAIn-person

About the Job

Requirements

  • A PhD in computational biology, computational chemistry, or a degree in computer science, applied mathematics, or statistics focused on modeling biological systems.
  • At least 10 years of relevant industry experience, including applying machine learning to diverse scientific problems.
  • Demonstrated leadership in machine learning for drug discovery, with a track record of building and applying predictive models to real-world, noisy, and multimodal scientific datasets.
  • Experience applying co-folding or hybrid models to enable productive ligand pose prediction, ideally on membrane proteins and flexible protein classes.
  • Previous work transferring learning or fine-tuning foundation models, using appropriate metrics to demonstrate model performance improvements and characterize applicability domain.
  • Experience leading teams and serving as the senior technical lead of cross-functional initiatives, with a track record of applying technical insight and scientific judgment to guide research strategy.
  • Expertise in scientific machine-learning and drug discovery dependencies such as PyTorch, scikit-learn, numpy, pandas, pyarrow, and RDKit.
  • Deep knowledge of modern machine-learning and statistical methods, including gradient boosting decision trees (XGBoost, LGBM), graph neural networks (GNN/D-MPNN), transformers, generative modeling, active learning, and Bayesian optimization.
  • Extensive experience with cloud and distributed computing environments, including AWS, GCP, or Azure, and building and maintaining containerized machine-learning workflows.
  • A strong track record in MLOps and partnering with software and platform engineering teams to define fit-for-purpose infrastructure for scientific applications.

Responsibilities

  • Lead Septerna’s Data Science team by providing technical direction, developing team capabilities, and integrating and prioritizing projects, primarily focused on machine-learning applications.
  • Develop and execute a roadmap for implementing state-of-the-art AI/ML approaches that use Septerna’s GPCR structural data to discover and refine novel chemical matter.
  • Identify productive emerging technologies and lead their integration into Septerna’s computational stack through internal development, strategic partnerships, or both.
  • Oversee and extend analysis pipelines, including DNA-encoded library (DEL), high-throughput screening (HTS), and assay-data workflows, and identify opportunities to advance Data Science as part of the broader Platform development team.
  • Advance and support ML-QSAR models leveraging internal and external assay and ADMET data to impact the efficiency of DMTA cycles and serve as a basis for generative chemistry workflows.
  • Refine data-engineering and cloud-infrastructure requirements while establishing best practices for data curation and model validation.

Desired Qualifications

  • Experience with molecular property prediction, generative chemistry, graph neural networks, protein–ligand modeling, sequence modeling, or physics-informed machine learning.
  • Hands-on structure-based drug discovery and experience collaborating closely with Computational Chemistry teams.
  • Publications, patents, or open-source contributions in relevant scientific or machine-learning domains.

About the Company

Septerna

Licenses GPCR discovery platform to pharma

Septerna develops and licenses a platform called Native Complex™ that enables drug discovery on G protein-coupled receptors (GPCRs) outside of cells. The platform reproduces GPCRs with their original structure, function, and dynamics, allowing scientists to design drugs based on GPCR structures and to perform ultra-large-scale screening across the full GPCR target class. This helps unlock GPCR targets that were previously hard to study and could lead to new medicines. The company differentiates itself by offering an industrial-scale, structure-based discovery workflow specifically for GPCRs, paired with a licensing business model for pharmaceutical companies. Its goal is to expand therapeutic options by turning more GPCRs—previously considered undruggable—into viable drug targets and to bring GPCR-targeted medicines to market through licensing and partnerships.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Septerna

See more jobs